8-Week Lifestyle Program Shows Promise for Preventing Cognitive Decline
A pilot trial of 'My Healthy Brain' targets multiple lifestyle factors to preserve brain health and reduce dementia risk in older adults.
Summary
My Healthy Brain is an 8-week group-based program designed to simultaneously address multiple lifestyle factors linked to cognitive decline and dementia risk. Conducted at Massachusetts General Hospital, this pilot trial enrolled 11 participants to test feasibility, acceptability, and early signals of effectiveness. The program targeted behaviors known to influence brain aging — including exercise, sleep, nutrition, and mental engagement — while also measuring self-determination and subjective well-being. Though small in scale, the trial aimed to generate proof-of-concept data to support larger future studies. The multimodal approach reflects growing evidence that no single intervention is sufficient for brain health; combining lifestyle strategies may offer synergistic protection against age-related cognitive impairment.
Detailed Summary
Cognitive decline and dementia represent among the most feared consequences of aging, yet no approved pharmaceutical cure exists. This reality has intensified interest in lifestyle-based prevention strategies, which accumulating evidence suggests can meaningfully reduce risk when applied early and consistently.
This pilot trial evaluated My Healthy Brain Version 2, an 8-week structured group program developed at Massachusetts General Hospital. The program directly targets several lifestyle domains associated with brain health, including physical activity, sleep quality, nutrition, stress management, and cognitive engagement. Eleven participants were enrolled, spanning adults concerned about aging, mild cognitive impairment, or dementia risk.
The primary outcomes focused on feasibility and acceptability — critical first steps before scaling any behavioral intervention. Secondary outcomes included improvement across the targeted lifestyle factors and measures of self-determination and subjective well-being. Although the trial was completed by December 2021, detailed results have not been published in the available abstract, limiting interpretation of effect sizes.
The significance of this work lies in its multimodal design. Single-intervention studies — examining exercise or diet alone — often show modest effects. Programs that bundle evidence-based lifestyle strategies may produce compounding benefits across different biological pathways implicated in neurodegeneration, including inflammation, vascular health, metabolic function, and neuroplasticity.
For clinicians and health-conscious individuals alike, a structured, group-based format offers practical advantages: social accountability, guided instruction, and the efficiency of addressing multiple risk factors simultaneously. If My Healthy Brain demonstrates sufficient feasibility and preliminary efficacy, it could serve as a scalable template for community-based brain health promotion.
Caveats are significant. The sample size of 11 participants is too small to draw any conclusions about efficacy. The trial's phase is listed as N/A, indicating this is an exploratory feasibility study, not a powered efficacy or randomized controlled trial.
Key Findings
- An 8-week group program simultaneously targets exercise, sleep, nutrition, and cognitive engagement to protect brain health.
- The trial assessed feasibility and acceptability — foundational steps before scaling lifestyle brain health interventions.
- Mild cognitive impairment and dementia-risk adults were included, broadening relevance across the aging spectrum.
- Self-determination and subjective well-being were measured as secondary outcomes alongside lifestyle behavior change.
- Multimodal lifestyle programs may offer synergistic protection unavailable from single-domain interventions.
Methodology
This was a single-arm pilot feasibility trial enrolling 11 participants across aging, mild cognitive impairment, and dementia-risk populations. The 8-week intervention (My Healthy Brain Version 2) was delivered in a group format at Massachusetts General Hospital. Primary outcomes centered on feasibility and acceptability; secondary outcomes included lifestyle behavior change, self-determination, and well-being.
Study Limitations
The enrollment of only 11 participants makes it impossible to draw reliable conclusions about efficacy or generalizability. This is an exploratory feasibility study with no control group, limiting causal inference. The summary is based on the abstract only; full methodology and results data are not publicly available.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: